191 related articles for article (PubMed ID: 19078632)
1. Long-Term Steroid Therapy in Duchenne Muscular Dystrophy-Positive Results versus Side Effects.
Schara U; Mortier ; Mortier W
J Clin Neuromuscul Dis; 2001 Jun; 2(4):179-83. PubMed ID: 19078632
[TBL] [Abstract][Full Text] [Related]
2. Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy.
Alman BA; Raza SN; Biggar WD
J Bone Joint Surg Am; 2004 Mar; 86(3):519-24. PubMed ID: 14996877
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
Manzur AY; Kuntzer T; Pike M; Swan A
Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
Manzur AY; Kuntzer T; Pike M; Swan A
Cochrane Database Syst Rev; 2004; (2):CD003725. PubMed ID: 15106215
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect.
Balaban B; Matthews DJ; Clayton GH; Carry T
Am J Phys Med Rehabil; 2005 Nov; 84(11):843-50. PubMed ID: 16244521
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-term steroids on cough efficiency and respiratory muscle strength in patients with Duchenne muscular dystrophy.
Daftary AS; Crisanti M; Kalra M; Wong B; Amin R
Pediatrics; 2007 Feb; 119(2):e320-4. PubMed ID: 17272595
[TBL] [Abstract][Full Text] [Related]
7. Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols.
Biggar WD; Politano L; Harris VA; Passamano L; Vajsar J; Alman B; Palladino A; Comi LI; Nigro G
Neuromuscul Disord; 2004 Sep; 14(8-9):476-82. PubMed ID: 15336688
[TBL] [Abstract][Full Text] [Related]
8. Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy.
King WM; Ruttencutter R; Nagaraja HN; Matkovic V; Landoll J; Hoyle C; Mendell JR; Kissel JT
Neurology; 2007 May; 68(19):1607-13. PubMed ID: 17485648
[TBL] [Abstract][Full Text] [Related]
9. Deflazacort treatment of Duchenne muscular dystrophy.
Biggar WD; Gingras M; Fehlings DL; Harris VA; Steele CA
J Pediatr; 2001 Jan; 138(1):45-50. PubMed ID: 11148511
[TBL] [Abstract][Full Text] [Related]
10. The impact of deflazacort on puberty in Duchenne muscular dystrophy.
Dooley JM; Bobbitt SA; Cummings EA
Pediatr Neurol; 2013 Oct; 49(4):292-3. PubMed ID: 23921283
[TBL] [Abstract][Full Text] [Related]
11. Steroid therapy and cardiac function in Duchenne muscular dystrophy.
Markham LW; Spicer RL; Khoury PR; Wong BL; Mathews KD; Cripe LH
Pediatr Cardiol; 2005; 26(6):768-71. PubMed ID: 15990951
[TBL] [Abstract][Full Text] [Related]
12. Intermittent versus daily regimen of prednisolone in ambulatory boys with Duchenne muscular dystrophy: A randomized, open-label trial.
Kochar GS; Sondhi V; Kabra SK; Yadav SL; Dwivedi SN; Gulati S
Muscle Nerve; 2022 Jan; 65(1):60-66. PubMed ID: 34617309
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment.
Wong BL; Rybalsky I; Shellenbarger KC; Tian C; McMahon MA; Rutter MM; Sawnani H; Jefferies JL
J Pediatr; 2017 Mar; 182():296-303.e1. PubMed ID: 28043681
[TBL] [Abstract][Full Text] [Related]
14. Impact of steroids on surgical experiences of patients with duchenne muscular dystrophy.
Dooley JM; Gordon KE; MacSween JM
Pediatr Neurol; 2010 Sep; 43(3):173-6. PubMed ID: 20691938
[TBL] [Abstract][Full Text] [Related]
15. Retrospective cohort study comparing the efficacy of prednisolone and deflazacort in children with muscular dystrophy: A 6 years' experience in a South Indian teaching hospital.
Petnikota H; Madhuri V; Gangadharan S; Agarwal I; Antonisamy B
Indian J Orthop; 2016 Sep; 50(5):551-557. PubMed ID: 27746500
[TBL] [Abstract][Full Text] [Related]
16. [Effects of corticosteroids in the management of Duchenne muscular dystrophy: our experience].
Rafia S; Pascual-Pascual SI; MartÃnez-Granero MA; Pascual-Castroviejo I
An Esp Pediatr; 2002 Dec; 57(6):518-23. PubMed ID: 12466073
[TBL] [Abstract][Full Text] [Related]
17. Fat embolism after fractures in Duchenne muscular dystrophy: an underdiagnosed complication? A systematic review.
Feder D; Koch ME; Palmieri B; Fonseca FLA; Carvalho AAS
Ther Clin Risk Manag; 2017; 13():1357-1361. PubMed ID: 29066903
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study.
McDonald CM; Henricson EK; Abresch RT; Duong T; Joyce NC; Hu F; Clemens PR; Hoffman EP; Cnaan A; Gordish-Dressman H;
Lancet; 2018 Feb; 391(10119):451-461. PubMed ID: 29174484
[TBL] [Abstract][Full Text] [Related]
19. Functional outcomes in Duchenne muscular dystrophy scoliosis: comparison of the differences between surgical and nonsurgical treatment.
Suk KS; Lee BH; Lee HM; Moon SH; Choi YC; Shin DE; Ha JW; Song KM; Kim HS
J Bone Joint Surg Am; 2014 Mar; 96(5):409-15. PubMed ID: 24599203
[TBL] [Abstract][Full Text] [Related]
20. [Update of steroid therapy for Duchenne muscular dystrophy].
Takeuchi F; Komaki H
No To Hattatsu; 2015 Jul; 47(4):266-71. PubMed ID: 26353447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
